COMP <GO>
TLSI vs BNR // PIOTROSKI F-SCORE QUALITY
TriSalus Life Sciences Inc. (NASDAQ) VS. Burning Rock Biotech Limited (NASDAQ) • 15-METRIC TALLY: TLSI 4
— BNR 4
▲ PIOTROSKI F-SCORE QUALITY LEADER: BNR
LAST: $3.86 (-1.78%) • MKT CAP: $237.7M
piotroski-score
4/9
LAST: $11.05 (-9.87%) • MKT CAP: $116.5M
piotroski-score
5/9
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (TLSI VS. BNR)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | TLSI | BNR | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 84.60% | 74.70% | +9.90 | TLSI | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -7.96% | -4.14% | -3.82 | BNR | /fcf-yield <GO> |
| Operating Margin | -59.70% | -10.20% | -49.50 | BNR | /operating-margins <GO> |
| Net Profit Margin | -60.00% | -10.30% | -49.70 | BNR | /net-margins <GO> |
| Revenue Growth (YoY) | 53.40% | 9.20% | +44.20 | TLSI | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 0.20 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality ACTIVE | 4/9 | 5/9 | -1.00 | BNR | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 44.9 | 39.1 | +5.80 | TLSI | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $237.7M | $116.5M | $121.1M | TLSI | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | TLSI REV | BNR REV | TLSI GROSS % | BNR GROSS % | TLSI FCF | BNR FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $45.2M | $77.2M | 84.6% | 74.7% | -$18.9M | -$4.8M |
| FY 2024 | $29.4M | $70.7M | 86.1% | 70.3% | -$41.2M | -$13.4M |
| FY 2023 | $18.5M | $75.7M | — | — | -$50.6M | -$36.0M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
TLSI // BETA —
BNR // BETA —